Fumaric Acid

Fumaric Acid

SCHEMBL6602929

C[C@H](N)Cn1ccc2ccc3ncccc3c21.O=C(O)C=CC(=O)O

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HTR2A known ✓ P28223 16/20 0.80
HTR2C known ✓ P28335 16/20 0.80
HTR2B known ✓ P41595 13/20 0.80
TLR7 Q9NYK1 1/20 0.40
PSMB5 P28074 3/20 0.38
PSMB1 P20618 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6602921 1.00 HTR2A (0.80) HTR2AHTR2CHTR2BTLR7PSMB5
Fumaric Acid SCHEMBL6602840 1.00 HTR2A (0.80) HTR2AHTR2CHTR2BTLR7PSMB5
Fumaric Acid SCHEMBL6602847 1.00 HTR2A (0.80) HTR2AHTR2CHTR2BTLR7PSMB5
SCHEMBL6605040 0.90 HTR2C (1.00) HTR2AHTR2CHTR2BTLR7
SCHEMBL6603614 0.90 HTR2C (1.00) HTR2AHTR2CHTR2BTLR7
SCHEMBL6604307 0.90 HTR2C (1.00) HTR2AHTR2CHTR2BTLR7
Hydrochloric Acid SCHEMBL6604400 0.89 HTR2C (0.97) HTR2AHTR2CHTR2BTLR7
Hydrochloric Acid SCHEMBL6607981 0.89 HTR2C (0.97) HTR2AHTR2CHTR2BTLR7
Fumaric Acid SCHEMBL6602844 0.84 HTR2A (0.56) HTR2AHTR2CHTR2BPSMB5
Fumaric Acid SCHEMBL6603600 0.81 HTR2A (0.82) HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109809-B1 PYRROLOQUINOLINES FOR TREATMENT OF OBESITY CEREBRUS PHARM LTD (GB) 2004-11-17 EP disclosed
US-6365598-B1 FOR THERAPY AND PROPHYLAXIS OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM; DAMAGE TO THE CENTRAL NERVOUS SYSTEM; CARDIOVASCULAR DISORDERS; GASTROINTESTINAL DISORDERS; DIABETES INSIPIDUS; AND SLEEP APNEA VERNALIS RESEARCH LIMITED (GB) 2002-04-02 US disclosed